D Joshua Liao

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. pmc Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variants
    Min Yang
    1 Hormel Institute, The University of Minnesota, Austin, MN 55912, USA
    J Cancer 2:386-400. 2011
  2. pmc The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat
    Aliccia Bollig-Fischer
    Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
    Int J Biomed Sci 8:51-63. 2012
  3. pmc Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing
    Chengfu Yuan
    Hormel Institute, University of Minnesota, Austin, MN, USA
    Cell Cycle 11:3356. 2012
  4. pmc Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
    Archana Thakur
    Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 110 E, Warren Ave, Detroit, Michigan 48201, USA
    Mol Cancer 7:11. 2008
  5. ncbi request reprint Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy
    D Joshua Liao
    Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, MN 55912, USA
    Crit Rev Oncog 13:93-158. 2007
  6. pmc Expression profile of microRNAs in c-Myc induced mouse mammary tumors
    Yuan Sun
    Hormel Institute, University of Minnesota, Austin, MN, 55912, USA
    Breast Cancer Res Treat 118:185-96. 2009
  7. pmc Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
    Archana Thakur
    Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA
    Clin Cancer Res 14:4427-36. 2008
  8. ncbi request reprint Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice
    Yong Wang
    Department of Pathology, Barbara Ann Karmanos Cancer Institute, Hudson Webber Cancer Research Center, Wayne State University School of Medicine, Detroit, MI, USA
    Cancer Res 67:3698-707. 2007
  9. pmc Identification of the cyclin D1b mRNA variant in mouse
    Jack Wu
    Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
    Mol Biol Rep 36:953-7. 2009
  10. doi request reprint Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation
    Min Yang
    Hormel Institute, University of Minnesota, 801 16th Avenue, NE, Austin, MN 55912, USA
    Mol Biol Rep 39:9247-56. 2012

Collaborators

Detail Information

Publications17

  1. pmc Complex alternative splicing of the smarca2 gene suggests the importance of smarca2-B variants
    Min Yang
    1 Hormel Institute, The University of Minnesota, Austin, MN 55912, USA
    J Cancer 2:386-400. 2011
    ....
  2. pmc The Predominant Proteins that React to the MC-20 Estrogen Receptor Alpha Antibody Differ in Molecular Weight between the Mammary Gland and Uterus in the Mouse and Rat
    Aliccia Bollig-Fischer
    Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
    Int J Biomed Sci 8:51-63. 2012
    ..These results suggest that while the lactating specific wt ERα alone or together with the MC20RP may sustain lactation, the MC20RP may support proliferation of the mammary gland and some mammary tumors...
  3. pmc Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing
    Chengfu Yuan
    Hormel Institute, University of Minnesota, Austin, MN, USA
    Cell Cycle 11:3356. 2012
    ..Comment on: Panneerselvam J, et al. Cell Cycle 2012; 11:2947-55...
  4. pmc Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice
    Archana Thakur
    Department of Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, 110 E, Warren Ave, Detroit, Michigan 48201, USA
    Mol Cancer 7:11. 2008
    ..To further evaluate the relevance of some of the selected differentially expressed genes, we investigated their expression pattern in human pancreatic cancer cell lines with high and low metastatic potentials...
  5. ncbi request reprint Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy
    D Joshua Liao
    Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, MN 55912, USA
    Crit Rev Oncog 13:93-158. 2007
    ....
  6. pmc Expression profile of microRNAs in c-Myc induced mouse mammary tumors
    Yuan Sun
    Hormel Institute, University of Minnesota, Austin, MN, 55912, USA
    Breast Cancer Res Treat 118:185-96. 2009
    ..These results suggest that certain mirRNAs and the chromosome 19 derived non-coding RNAs may mediate c-myc induced mammary carcinogenesis...
  7. pmc Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells
    Archana Thakur
    Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, USA
    Clin Cancer Res 14:4427-36. 2008
    ..In this study, we further investigated whether RSK4 inhibits or promotes breast tumor growth and progression...
  8. ncbi request reprint Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice
    Yong Wang
    Department of Pathology, Barbara Ann Karmanos Cancer Institute, Hudson Webber Cancer Research Center, Wayne State University School of Medicine, Detroit, MI, USA
    Cancer Res 67:3698-707. 2007
    ..In summary, overexpression of cyclin D1 may commit mammary epithelia to a tumor-prone phenotype in which cooperation with other genes, such as synergy with c-myc, may lead to a more aggressive phenotype...
  9. pmc Identification of the cyclin D1b mRNA variant in mouse
    Jack Wu
    Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA
    Mol Biol Rep 36:953-7. 2009
    ..It appears to be expressed ubiquitously and differentially in various mouse cell lines and tissues and its level might be proportional to that of the canonical endogenous cyclin D1a mRNA...
  10. doi request reprint Splicing of mouse p53 pre-mRNA does not always follow the "first come, first served" principle and may be influenced by cisplatin treatment and serum starvation
    Min Yang
    Hormel Institute, University of Minnesota, 801 16th Avenue, NE, Austin, MN 55912, USA
    Mol Biol Rep 39:9247-56. 2012
    ..It remains possible that these p53-ICTs are splicing intermediates existing as a mechanism for the cell to respond more promptly to a demand for more p53 and that p53 protein may be required for a normal life of MEF...
  11. doi request reprint New methods as alternative or corrective measures for the pitfalls and artifacts of reverse transcription and polymerase chain reactions (RT-PCR) in cloning chimeric or antisense-accompanied RNA
    Chengfu Yuan
    Hormel Institute, University of Minnesota, Austin, MN, USA
    RNA Biol 10:958-67. 2013
    ..The ERP and overlapping antisense together set complex pitfalls, which one should be aware of. ..
  12. pmc Pseudogenes as weaknesses of ACTB (Actb) and GAPDH (Gapdh) used as reference genes in reverse transcription and polymerase chain reactions
    Yuan Sun
    Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America
    PLoS ONE 7:e41659. 2012
    ..We also propose a standard operation procedure in which design of primers for RT-PCR starts from avoiding mis-priming PGs and all primers need be tested for specificity with both cDNA and gDNA...
  13. pmc CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells
    Yuan Sun
    Department of Pathology, Guangxi Medical University, Nanning, Guangxi 530 021, P R China Hormel Institute, University of Minnesota, Austin, MN, USA
    J Carcinog 11:12. 2012
    ..The elevated cyclinD1 in some types of cancers is believed to be associated with tumor progression and response to systemic treatments...
  14. pmc Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells
    Yuan Sun
    1 Hormel Institute, University of Minnesota, Austin, MN 55912, USA
    J Cancer 2:36-51. 2011
    ..Decreased phosphorylation of Rb by D1-CDK4/6 and decreased p27kip1 protein level may be part of the underlying mechanism...
  15. pmc Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families
    Ayman El-Kady
    Department of the University of Minnesota, Hormel Institute, Austin, MN 55912, USA
    J Carcinog 10:24. 2011
    ..This study aims to determine whether and how cyclin D1 (D1) and c-Myc influence the response of pancreatic cancer cells to CDDP...
  16. doi request reprint Epicatechin-rich cocoa polyphenol inhibits Kras-activated pancreatic ductal carcinoma cell growth in vitro and in a mouse model
    Hifzur Rahman Siddique
    Department of Molecular Chemoprevention and Therapeutics, The Hormel Institute, University of Minnesota, Austin, MN, USA
    Int J Cancer 131:1720-31. 2012
    ..We suggest that (i) Kras-driven cell-based model is an excellent model for testing intervention agents and (ii) CP is a promising chemopreventive agent for inhibiting PDAC development...
  17. pmc A quick, cost-free method of purification of DNA fragments from agarose gel
    Yuan Sun
    1 Hormel Institute, The University of Minnesota, Austin, MN 55912, USA
    J Cancer 3:93-5. 2012
    ....